Product Images Gabapentin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 9 images provide visual information about the product associated with Gabapentin NDC 68462-127 by Glenmark Pharmaceuticals Inc., Usa, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure1

Figure1

Figure2

Figure2

This appears to be a chart or table representing a study of pain scores over a period of time. The study includes a "baseline" measurement and two different dosages of Gabapentin (1800 mg/day and 2400 mg/day) compared to a placebo. However, without more context or additional information it is not possible to provide a more detailed or useful description.*

Figure3

Figure3

This text seems to be a part of a figure, and it represents a graph showing the percentage of patients classified as responders in two controlled PHN (Postherpetic Neuralgia) studies. It displays the proportion of patients reporting a minimum reduction of 50% in pain score at endpoint for both studies along with the respective placebo and treatment groups. The study names are also mentioned as Study 1 and Study 2. Additionally, there are some symbols like *, +, and numerical values like 0, 10, 20, up to 100.*

Figure4

Figure4

LBL600mg100s

LBL600mg100s

This is a prescription medication called Gabapentin, available in the form of tablets. It is supplied by Glenmark Pharmaceuticals with the National Drug Code (NOC) 68462-126-01. The medication guide is provided separately to each patient by a pharmacist. The description includes information about the total quantity of the tablets, 100.*

LBL800mg100s

LBL800mg100s

Logo.jpg - Logo

Logo.jpg - Logo

Structure.jpg - Structure

Structure.jpg - Structure

Equation.jpg - equation

Equation.jpg - equation

This text appears to be a mathematical formula for calculating Hbr (hemoglobin concentration in red blood cells). It involves using the age and weight of the patient, as well as their serum creatinine levels, and may include an adjustment for female patients. However, without additional context it is not possible to determine the purpose or significance of this calculation.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.